Table 1.
ELISA anti-MUC1 and anti-Thelper antibody titers after four immunizations with various preparations
Immunization* | IgG total MUC1 | IgG1 MUC1 | IgG2a MUC1 | IgG2b MUC1 | IgG3 MUC1 | IgM MUC1 | IgG total Thelper |
1 (no tumor induced) | 31,900 | 10,600 | 10,000 | 15,500 | 3,900 | 100 | 2,100 |
1 | 30,200 | 16,000 | 6,600 | 10,700 | 3,900 | 50 | 3,000 |
2 | 12,900 | 10,400 | 4,100 | 4,500 | 700 | 100 | 1,000 |
3 | 1,300 | 0 | 100 | 900 | 0 | 0 | 50 |
4 + 5 | 300 | 0 | 0 | 200 | 0 | 0 | 1,000 |
5 | 0 | 0 | 200 | 0 | 0 | 50 | 50 |
Anti-MUC1 and anti-Thelper antibody titers are presented as median values for groups of 4–13 mice. ELISA plates were coated with BSA-MI-CTSAPDT(αGalNAc)RPAP conjugate for anti-MUC1 antibody titers or NeutrAvidin-biotin-Thelper for anti-Thelper antibody titers. Titers were determined by linear regression analysis, with plotting of dilution versus absorbance. Titers are defined as the highest dilution yielding an optical density of 0.1 or greater relative to normal control mouse sera.
*Liposomal preparations were used. MMT tumors were induced between the third and fourth immunization.